These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 30468131)

  • 41. Differential Regulation of Interferon Responses by Ebola and Marburg Virus VP35 Proteins.
    Edwards MR; Liu G; Mire CE; Sureshchandra S; Luthra P; Yen B; Shabman RS; Leung DW; Messaoudi I; Geisbert TW; Amarasinghe GK; Basler CF
    Cell Rep; 2016 Feb; 14(7):1632-1640. PubMed ID: 26876165
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ebola virus sequesters IRF3 in viral inclusion bodies to evade host antiviral immunity.
    Zhu L; Jin J; Wang T; Hu Y; Liu H; Gao T; Dong Q; Jin Y; Li P; Liu Z; Huang Y; Liu X; Cao C
    Elife; 2024 Jan; 12():. PubMed ID: 38285487
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ebola Virus Inclusion Body Formation and RNA Synthesis Are Controlled by a Novel Domain of Nucleoprotein Interacting with VP35.
    Miyake T; Farley CM; Neubauer BE; Beddow TP; Hoenen T; Engel DA
    J Virol; 2020 Jul; 94(16):. PubMed ID: 32493824
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immune evasion in ebolavirus infections.
    Audet J; Kobinger GP
    Viral Immunol; 2015 Feb; 28(1):10-8. PubMed ID: 25396298
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The VP35 protein of Ebola virus impairs dendritic cell maturation induced by virus and lipopolysaccharide.
    Jin H; Yan Z; Prabhakar BS; Feng Z; Ma Y; Verpooten D; Ganesh B; He B
    J Gen Virol; 2010 Feb; 91(Pt 2):352-61. PubMed ID: 19828757
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Whole-genome expression profiling reveals that inhibition of host innate immune response pathways by Ebola virus can be reversed by a single amino acid change in the VP35 protein.
    Hartman AL; Ling L; Nichol ST; Hibberd ML
    J Virol; 2008 Jun; 82(11):5348-58. PubMed ID: 18353943
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel activities by ebolavirus and marburgvirus interferon antagonists revealed using a standardized in vitro reporter system.
    Guito JC; Albariño CG; Chakrabarti AK; Towner JS
    Virology; 2017 Jan; 501():147-165. PubMed ID: 27930961
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers.
    Warfield KL; Swenson DL; Olinger GG; Nichols DK; Pratt WD; Blouch R; Stein DA; Aman MJ; Iversen PL; Bavari S
    PLoS Pathog; 2006 Jan; 2(1):e1. PubMed ID: 16415982
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ebolavirus Species-Specific Interferon Antagonism Mediated by VP24.
    Ramanathan P; Tigabu B; Santos RI; Ilinykh PA; Kuzmina N; Vogel OA; Thakur N; Ahmed H; Wu C; Amarasinghe GK; Basler CF; Bukreyev A
    Viruses; 2023 Apr; 15(5):. PubMed ID: 37243162
    [TBL] [Abstract][Full Text] [Related]  

  • 50. VP24 is a molecular determinant of Ebola virus virulence in guinea pigs.
    Mateo M; Carbonnelle C; Reynard O; Kolesnikova L; Nemirov K; Page A; Volchkova VA; Volchkov VE
    J Infect Dis; 2011 Nov; 204 Suppl 3():S1011-20. PubMed ID: 21987737
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development and Validation of a Novel Dual Luciferase Reporter Gene Assay to Quantify Ebola Virus VP24 Inhibition of IFN Signaling.
    Fanunza E; Frau A; Sgarbanti M; Orsatti R; Corona A; Tramontano E
    Viruses; 2018 Feb; 10(2):. PubMed ID: 29495311
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structural basis for Marburg virus VP35-mediated immune evasion mechanisms.
    Ramanan P; Edwards MR; Shabman RS; Leung DW; Endlich-Frazier AC; Borek DM; Otwinowski Z; Liu G; Huh J; Basler CF; Amarasinghe GK
    Proc Natl Acad Sci U S A; 2012 Dec; 109(50):20661-6. PubMed ID: 23185024
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular basis for ebolavirus VP35 suppression of human dendritic cell maturation.
    Yen B; Mulder LC; Martinez O; Basler CF
    J Virol; 2014 Nov; 88(21):12500-10. PubMed ID: 25142601
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Herpes Simplex Virus 1 Serine Protease VP24 Blocks the DNA-Sensing Signal Pathway by Abrogating Activation of Interferon Regulatory Factor 3.
    Zhang D; Su C; Zheng C
    J Virol; 2016 Jun; 90(12):5824-5829. PubMed ID: 27076640
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Advances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola Virus.
    Dhama K; Karthik K; Khandia R; Chakraborty S; Munjal A; Latheef SK; Kumar D; Ramakrishnan MA; Malik YS; Singh R; Malik SVS; Singh RK; Chaicumpa W
    Front Immunol; 2018; 9():1803. PubMed ID: 30147687
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A review on the antagonist Ebola: A prophylactic approach.
    Khan FN; Qazi S; Tanveer K; Raza K
    Biomed Pharmacother; 2017 Dec; 96():1513-1526. PubMed ID: 29208326
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibiting pyrimidine biosynthesis impairs Ebola virus replication through depletion of nucleoside pools and activation of innate immune responses.
    Luthra P; Naidoo J; Pietzsch CA; De S; Khadka S; Anantpadma M; Williams CG; Edwards MR; Davey RA; Bukreyev A; Ready JM; Basler CF
    Antiviral Res; 2018 Oct; 158():288-302. PubMed ID: 30144461
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Herbal Lead as Ideal Bioactive Compounds Against Probable Drug Targets of Ebola Virus in Comparison with Known Chemical Analogue: A Computational Drug Discovery Perspective.
    Setlur AS; Naik SY; Skariyachan S
    Interdiscip Sci; 2017 Jun; 9(2):254-277. PubMed ID: 26857866
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vaccine potential of Ebola virus VP24, VP30, VP35, and VP40 proteins.
    Wilson JA; Bray M; Bakken R; Hart MK
    Virology; 2001 Aug; 286(2):384-90. PubMed ID: 11485406
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sudan Ebolavirus VP35-NP Crystal Structure Reveals a Potential Target for Pan-Filovirus Treatment.
    Landeras-Bueno S; Oda SI; Norris MJ; Li Salie Z; Guenaga J; Wyatt RT; Saphire EO
    mBio; 2019 Jul; 10(4):. PubMed ID: 31337716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.